← Back to Search

Support-t Online Training for Type 1 Diabetes Transition Care (Support-t Trial)

N/A

Recruiting

Led By Anne-Sophie Brazeau, PhD

Research Sponsored by Anne-Sophie Brazeau

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6, 12, 18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how an online training and peer support platform can help teens with Type 1 Diabetes transition to adult care.

Who is the study for?

This trial is for 14-16 year olds with Type 1 Diabetes who are patients at one of four specific pediatric diabetes clinics in Quebec. They must have internet access, an active email, and speak English or French. It's not specified who can't join.

What is being tested?

The study tests 'Support-t', an online training and peer support platform designed to help youths with Type 1 Diabetes as they prepare to move from child to adult care services. The effect on blood sugar control, health outcomes, and mental well-being will be compared with usual care.

What are the potential side effects?

Since 'Support-t' is a non-medical intervention focusing on education and social support, it does not have typical medical side effects. However, participants may experience stress or anxiety related to the use of technology or the transition process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6, 12, 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6, 12, 18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6, 12, 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from Baseline Hemaglobin A1c (HbA1c) at 18 months

Secondary study objectives

Change from Baseline Hemaglobin A1c (HbA1c) at 6 and 12 months

Continuous Glucose Monitoring (CGM) - % Coefficient of variation

Continuous Glucose Monitoring (CGM) - % Time above range

+15 more

Other study objectives

Engagement with Support-t platform (Health Care Provider) - content accessed

Engagement with Support-t platform (Health Care Provider) - downloaded documents

Engagement with Support-t platform (Health Care Provider) - time in minutes on platform

+11 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Support-t plus usual diabetes careExperimental Treatment1 Intervention

Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.

Group II: Usual diabetes care onlyActive Control1 Intervention

Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.

Do I qualify?Apply below to find out